Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction

Hyun S. Lee, Yoon Chang Koo, Hyung Joo Suh, Kyung Yong Kim, Kwang Won Lee

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Aim of the study: The aqueous extract of Terminalia chebular fruits was reported to have anti-hyperglycemia and anti-diabetic complication effects. The present study therefore investigated the protective mechanism of chebulic acid, a phenolcarboxylic acid compound isolated from the ripe fruits of Terminalia chebula against advanced glycation endproducts (AGEs)-induced endothelial cell dysfunction. Materials and methods: To investigate the protective mechanism of chebulic acid against vascular endothelial dysfunction human umbilical vein endothelial cells (HUVEC) were treated with chebulic acid in the presence/absence of glyceraldehyde-related AGEs (glycer-AGEs). Results: HUVEC incubated with 100 μg/ml of glycer-AGEs had significantly enhanced reactive oxygen species formation, whereas the treatment of chebulic acid dose-dependently reduced glycer-AGE-induced formation to 108.2 ± 1.9% for 25 μM versus 137.8 ± 1.1% for glycer-AGEs treated alone. The transendothelial electrical resistance (TER) value of the glycer-AGEs group was dramatically decreased to 76.9 ± 2.2% compared to the control, whereas chebulic acid treatment prevented glycer-AGE-induced TER change with a value of 91.3 ± 5.3%. The incubation of confluent HUVEC with 100 μg/ml of glycer-AGEs for 24. h remarkably increased the adhesion of human monocytic THP-1 cells compared to non-stimulated HUVEC. These increases in HUVEC adhesiveness were dose-dependently reduced by chebulic acid. Conclusions: The present study shows the effects of chebulic acid against the progression of AGE-induced endothelial cell dysfunction suggesting that this compound may constitute a promising intervention agent against diabetic vascular complications.

Original languageEnglish
Pages (from-to)567-574
Number of pages8
JournalJournal of Ethnopharmacology
Volume131
Issue number3
DOIs
Publication statusPublished - 2010 Oct 1

Fingerprint

Terminalia
Glyceraldehyde
Human Umbilical Vein Endothelial Cells
Endothelial Cells
Electric Impedance
Fruit
Diabetic Angiopathies
Adhesiveness
Diabetes Complications
chebulic acid
Hyperglycemia
Blood Vessels
Reactive Oxygen Species
Acids

Keywords

  • Advanced glycation endproducts
  • Chebulic acid
  • Diabetic complications
  • Endothelial dysfunction
  • Terminaila chebula

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction. / Lee, Hyun S.; Koo, Yoon Chang; Suh, Hyung Joo; Kim, Kyung Yong; Lee, Kwang Won.

In: Journal of Ethnopharmacology, Vol. 131, No. 3, 01.10.2010, p. 567-574.

Research output: Contribution to journalArticle

@article{55ecced37c254891bf7902611c4bba99,
title = "Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction",
abstract = "Aim of the study: The aqueous extract of Terminalia chebular fruits was reported to have anti-hyperglycemia and anti-diabetic complication effects. The present study therefore investigated the protective mechanism of chebulic acid, a phenolcarboxylic acid compound isolated from the ripe fruits of Terminalia chebula against advanced glycation endproducts (AGEs)-induced endothelial cell dysfunction. Materials and methods: To investigate the protective mechanism of chebulic acid against vascular endothelial dysfunction human umbilical vein endothelial cells (HUVEC) were treated with chebulic acid in the presence/absence of glyceraldehyde-related AGEs (glycer-AGEs). Results: HUVEC incubated with 100 μg/ml of glycer-AGEs had significantly enhanced reactive oxygen species formation, whereas the treatment of chebulic acid dose-dependently reduced glycer-AGE-induced formation to 108.2 ± 1.9{\%} for 25 μM versus 137.8 ± 1.1{\%} for glycer-AGEs treated alone. The transendothelial electrical resistance (TER) value of the glycer-AGEs group was dramatically decreased to 76.9 ± 2.2{\%} compared to the control, whereas chebulic acid treatment prevented glycer-AGE-induced TER change with a value of 91.3 ± 5.3{\%}. The incubation of confluent HUVEC with 100 μg/ml of glycer-AGEs for 24. h remarkably increased the adhesion of human monocytic THP-1 cells compared to non-stimulated HUVEC. These increases in HUVEC adhesiveness were dose-dependently reduced by chebulic acid. Conclusions: The present study shows the effects of chebulic acid against the progression of AGE-induced endothelial cell dysfunction suggesting that this compound may constitute a promising intervention agent against diabetic vascular complications.",
keywords = "Advanced glycation endproducts, Chebulic acid, Diabetic complications, Endothelial dysfunction, Terminaila chebula",
author = "Lee, {Hyun S.} and Koo, {Yoon Chang} and Suh, {Hyung Joo} and Kim, {Kyung Yong} and Lee, {Kwang Won}",
year = "2010",
month = "10",
day = "1",
doi = "10.1016/j.jep.2010.07.039",
language = "English",
volume = "131",
pages = "567--574",
journal = "Journal of Ethnopharmacology",
issn = "0378-8741",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction

AU - Lee, Hyun S.

AU - Koo, Yoon Chang

AU - Suh, Hyung Joo

AU - Kim, Kyung Yong

AU - Lee, Kwang Won

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Aim of the study: The aqueous extract of Terminalia chebular fruits was reported to have anti-hyperglycemia and anti-diabetic complication effects. The present study therefore investigated the protective mechanism of chebulic acid, a phenolcarboxylic acid compound isolated from the ripe fruits of Terminalia chebula against advanced glycation endproducts (AGEs)-induced endothelial cell dysfunction. Materials and methods: To investigate the protective mechanism of chebulic acid against vascular endothelial dysfunction human umbilical vein endothelial cells (HUVEC) were treated with chebulic acid in the presence/absence of glyceraldehyde-related AGEs (glycer-AGEs). Results: HUVEC incubated with 100 μg/ml of glycer-AGEs had significantly enhanced reactive oxygen species formation, whereas the treatment of chebulic acid dose-dependently reduced glycer-AGE-induced formation to 108.2 ± 1.9% for 25 μM versus 137.8 ± 1.1% for glycer-AGEs treated alone. The transendothelial electrical resistance (TER) value of the glycer-AGEs group was dramatically decreased to 76.9 ± 2.2% compared to the control, whereas chebulic acid treatment prevented glycer-AGE-induced TER change with a value of 91.3 ± 5.3%. The incubation of confluent HUVEC with 100 μg/ml of glycer-AGEs for 24. h remarkably increased the adhesion of human monocytic THP-1 cells compared to non-stimulated HUVEC. These increases in HUVEC adhesiveness were dose-dependently reduced by chebulic acid. Conclusions: The present study shows the effects of chebulic acid against the progression of AGE-induced endothelial cell dysfunction suggesting that this compound may constitute a promising intervention agent against diabetic vascular complications.

AB - Aim of the study: The aqueous extract of Terminalia chebular fruits was reported to have anti-hyperglycemia and anti-diabetic complication effects. The present study therefore investigated the protective mechanism of chebulic acid, a phenolcarboxylic acid compound isolated from the ripe fruits of Terminalia chebula against advanced glycation endproducts (AGEs)-induced endothelial cell dysfunction. Materials and methods: To investigate the protective mechanism of chebulic acid against vascular endothelial dysfunction human umbilical vein endothelial cells (HUVEC) were treated with chebulic acid in the presence/absence of glyceraldehyde-related AGEs (glycer-AGEs). Results: HUVEC incubated with 100 μg/ml of glycer-AGEs had significantly enhanced reactive oxygen species formation, whereas the treatment of chebulic acid dose-dependently reduced glycer-AGE-induced formation to 108.2 ± 1.9% for 25 μM versus 137.8 ± 1.1% for glycer-AGEs treated alone. The transendothelial electrical resistance (TER) value of the glycer-AGEs group was dramatically decreased to 76.9 ± 2.2% compared to the control, whereas chebulic acid treatment prevented glycer-AGE-induced TER change with a value of 91.3 ± 5.3%. The incubation of confluent HUVEC with 100 μg/ml of glycer-AGEs for 24. h remarkably increased the adhesion of human monocytic THP-1 cells compared to non-stimulated HUVEC. These increases in HUVEC adhesiveness were dose-dependently reduced by chebulic acid. Conclusions: The present study shows the effects of chebulic acid against the progression of AGE-induced endothelial cell dysfunction suggesting that this compound may constitute a promising intervention agent against diabetic vascular complications.

KW - Advanced glycation endproducts

KW - Chebulic acid

KW - Diabetic complications

KW - Endothelial dysfunction

KW - Terminaila chebula

UR - http://www.scopus.com/inward/record.url?scp=77956647697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956647697&partnerID=8YFLogxK

U2 - 10.1016/j.jep.2010.07.039

DO - 10.1016/j.jep.2010.07.039

M3 - Article

C2 - 20659546

AN - SCOPUS:77956647697

VL - 131

SP - 567

EP - 574

JO - Journal of Ethnopharmacology

JF - Journal of Ethnopharmacology

SN - 0378-8741

IS - 3

ER -